Skip to main content
. 2021 Oct 13;7(42):eabi6648. doi: 10.1126/sciadv.abi6648

Fig. 5. miR-1/133a control expression of ECM components in cardiomyocytes via OSMR and FGFR1.

Fig. 5.

(A) Wheat germ agglutinin (WGA) immunofluorescence and trichrome staining of ECM deposition in heart sections from adult ctrl and knockout mice [ctrl, n = 2; dKO, n = 2; tKO (OR), n = 5; tKO (FR1), n = 5]. Scale bars, 20 μm. (B) Top 10 GO terms enriched in dKO compared to ctrl hearts. Terms associated with ECM are in red. (C) Microarray-based GSEA of adult ctrl and knockout hearts and heatmap of the 10 most up-regulated genes in dKO hearts derived from the respective gene set. Additional knockout of Osmr (tKO OR) or Fgfr1 (tKO FR1) or treatment with UO126 [ctrl: n = 4; dKO, dKO + UO, tKO (OR), tKO (FR1): n = 3] abolished enrichment in dKO hearts. (D and E) RT-qPCR analysis of different ECM genes in adult dKO (n = 4) and control cardiomyocytes (n = 5) and noncardiomyocytes (control, n = 4; dKO, n = 2 to 3) from 15-week-old mice, 3 weeks after tamoxifen administration. (F) Depiction of expression changes in neonatal and adult mice hearts of genes affecting ECM stiffness. (G and H) RT-qPCR analysis of agrin (F) (ctrl, n = 4; dKO, n = 3) and periostin (G) (ctrl, n = 4; dKO, n = 4) expression in isolated cardiomyocytes and noncardiomyocytes (n = 5) from adult dKO hearts compared to controls (two-tailed unpaired t tests). (I) Heatmap of genes related to soft ECM increased in miR-1/133a dKO versus wild-type (WT) hearts. Additional deletion of Osmr (tKO OR) or Fgfr1 (tKO FR1) or treatment with UO126 abolished increased expression. *P < 0.05 and ****P < 0.0001.